1-3 of 3
Sarah E. Stump
Close
Sort by
Journal Articles

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Lydia Benitez, Kayleigh R. Marx, Kaitlyn M. Buhlinger, Stephen M. Clark, Justin H. Reid, Caitlin R Rausch, Katie S Gatwood, Sarah E. Stump, Richa Shah, Jenna Ciervo, Jeffrey Baron, Bernard Lawrence Marini, Anthony J. Perissinotti, Madeline Waldron, Benyam Muluneh
Journal: Blood
Blood (2023) 142 (Supplement 1): 4267.
https://doi.org/10.1182/blood-2023-189637
Published: 2023
Journal Articles

Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients

Maryam Sarraf Yazdy, MD, Anthony R. Mato, MDMSCE, Lindsey E. Roeker, MD, Umair Jarral, MD, Chaitra S. Ujjani, MD, Mazyar Shadman, MD MPH, Alan Skarbnik, MD, Kate J Whitaker, BA, Isaac Deonarine, Charlene C. Kabel, PharmD, Sarah E. Stump, PharmD, BCPS, BCOP, Julie Goodfriend, John M. Pagel, MD PhD DSc, Neil Bailey, MSc, Krish Patel, MD, Ryan Jacobs, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Andre Goy, MD, Catherine C. Coombs, MD, Benyam Muluneh, PharmD, Sirin Khajavian, MD, Nicole Lamanna, MD, Hanna Weissbrot, BS, Jessica Weiss, Bruce D. Cheson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4311.
https://doi.org/10.1182/blood-2019-130062
Published: 2019
Journal Articles

Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia

Ryan J. Daley, PharmD, Sridevi Rajeeve, MD, Charlene C. Kabel, PharmD, Jeremy J. Pappacena, PharmD, BCOP, Sarah E. Stump, PharmD, BCPS, BCOP, Jessica A. Lavery, MS, Martin S. Tallman, MD, Mark B. Geyer, MD, Jae H. Park, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3816.
https://doi.org/10.1182/blood-2019-124727
Published: 2019